首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression
【24h】

TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression

机译:TNF-α是通过肝CCL20表达的上调诱导小鼠致命自身免疫性肝炎的诱导

获取原文
获取原文并翻译 | 示例
           

摘要

It is unclear what roles TNF-bas in the development of autoimmune hepatitis (AIH) and whether AIH is responsive to anti-TNF-齏e recently developed a mouse model of fatal AIH that develops in PD-1-deficient mice thymectomized three days after birth, finding that CCR6-CCL20 axis-dependent migration of dysregulated splenic T cells is crucial to induce AIH. In this study, we show the indispensable role of TNF-cn the development of AIH. Administering anti-TNF-jrevented the induction, but treatment by anti-TNF-[fter the induction did not suppress progression. Administering anti-TNF-^id not prevent splenic T-cell activation, but did suppress hepatic CCL20 expression. In contrast, administering anti-CCL20 suppressed AIH but not elevated serum TNF-fevels. TNF-mtimulation enhanced CCL20 expression in hepatocytes. These findings suggest that TNF-cs essential in the induction of AIH through upregulation of hepatic CCL20 expression, which allows migration of dysregulated splenic T cells.
机译:目前尚不清楚TNF-BAC在自身免疫性肝炎(AIH)的发展中的作用以及AIH是否响应于抗TNF-齑E最近开发了致命AIH的小鼠模型,其在三天之后的PD-1缺陷小鼠中发展 出生,发现CCR6-CCL20依赖于失调的脾T细胞的轴依赖性迁移至关重要,以诱导AIH。 在这项研究中,我们展示了TNF-CN的不可或缺的作用AIH的发展。 施用抗TNF-JREVENTED诱导,但通过抗TNF-[诱导的诱导治疗不抑制进展。 施用抗TNF-^ ID不妨碍脾脏T细胞活化,但确实抑制了肝CCL20表达。 相反,施用抗CCL20抑制αH但未升高的血清TNF-FEV。 TNF-mTimulation增强了肝细胞中的CCL20表达。 这些发现表明,通过肝CCl20表达的上调诱导AIH诱导TNF-CS,这允许迁移失调的脾脏T细胞。

著录项

  • 来源
  • 作者单位

    Center for Innovation in Immunoregulative Technology and Therapeutics Graduate School of Medicine;

    Center for Innovation in Immunoregulative Technology and Therapeutics Graduate School of Medicine;

    Center for Innovation in Immunoregulative Technology and Therapeutics Graduate School of Medicine;

    Center for Innovation in Immunoregulative Technology and Therapeutics Graduate School of Medicine;

    Center for Innovation in Immunoregulative Technology and Therapeutics Graduate School of Medicine;

    Center for Innovation in Immunoregulative Technology and Therapeutics Graduate School of Medicine;

    Division of Immune Regulation Institute for Genome Research University of Tokushima Tokushima;

    Department of Gastroenterology and Hepatology Graduate School of Medicine Kyoto University Kyoto;

    Center for Innovation in Immunoregulative Technology and Therapeutics Graduate School of Medicine;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学免疫学;
  • 关键词

    Autoimmune hepatitis; CCL20; Mouse model; TNF-ntagonist; TNF-?;

    机译:自身免疫性肝炎;CCL20;小鼠模型;TNF- [拮抗剂;TNF-?;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号